CML Horizons 2017: Learn. Share. Grow.
26th – 28th May 2017, Frankfurt, Germany
CML 101. Overview of CML Horizons 2017 (Pat García-González) – PDF – Video Webstream
Parallel Regional Networking Sessions
- Africa: Access in Africa – Building Bridges (Bahija Goumi)
- Asia: Living CML Asia (Rod Padua)
- Europe: European Patient Advocacy and Key European Projects (Jan Geissler) – PDF – Video Webstream
Welcome
- Welcome (Giora Sharf) – PDF – Video Webstream
- Update on the CML Advocates Network (Jan Geissler and Giora Sharf) – PDF – Video Webstream
- Tribute to Abdoul Nasser Boukhari (Bahija Gouimi) – Video Webstream
Advocacy Session #1: Patient Advocacy – How does drug development work
- Keynote: Why the voice of patients matters in research and regulatory affairs (Bettina Ryll) – PDF – Video Webstream
- The basics of medicines development and how to educate yourself about medicines R&D (Jan Geissler) – PDF – Video Webstream
Medical Session #1: CML therapies in 2017: Evolution, hope and challenges
- Guidelines and real world: Management of CML in chronic and advanced phases (Carolina Pavlovsky) – PDF – Video Webstream
- Management of CML in countries with limited access to treatment and diagnostics (Ivana Urosevic) – PDF – Video Webstream
- Role of combination treatments, Interferon and immunotherapy in CML (Andreas Burchert) – PDF – Video Webstream
Presentation of nominees for elections of the CML Horizons Steering Committee 2018-2019
Medical Session #2: Discontinuing treatment – what we know & what the future brings
- Stopping treatment – how much we understand about mechanisms to stop successfully today, and where are the limits? (Andreas Hochhaus) – PDF – Video Webstream
- Patient perspective on living with TFR in all four phases – and the CML Advocates TFR Workgroup (Giora Sharf) – PDF – Video Webstream
- Debate: Are we ready for recommendations to stop outside of trials? (Andreas Hochhaus, Jane Apperley and Carolina Pavlovsky) – Video Webstream
Advocacy Session #3: Access: The good, bad and ugly
- Access to treatment in western countries, and the “can of worms” (Jan Geissler) – PDF – Video Webstream
- Access to treatment in low and middle income countries, and access programmes (Pat García-González) – PDF – Video Webstream
- Debate: What can the community do about improving access to treatment and monitoring? – Video Webstream
Medical Session #3: Side effects, pregnancy and fertility
- Long-term side effects, comorbidities & their impact on choice of treatment CML management and quality of life (Andreas Hochhaus) – PDF – Video Webstream
- Pregnancy & Fertility (Jane Aperley) – PDF – Video Webstream
Advocacy-Session #4: Best practices in patient advocacy
- Euriclea: The new nurse role in supporting Italian CML patients (Felice Bombaci) – PDF – Video Webstream
- Starting organization from scratch (Boris Machavariani) – PDF – Video Webstream
- CML care to a next level (Jan de Jong) – PDF – Video Webstream
- Survey patient-to-patient on Side Effects (Toni Montserrat) – PDF – Video Webstream
- The Canadian CML Network Patient Hub (Lisa Machado) – PDF – Video Webstream
- Annual Family Meeting (Yunus Borowczak) – PDF – Video Webstream
- CML patients’ journey (Giora Sharf) – PDF – Video Webstream
- “Free Hugs” campaign (Rod Padua) – PDF – Video Webstream
CML Horizons Steering Committee 2018-2019: Results of the elections – Video Webstream
Report from Regional Sessions – PDF – Video Webstream
Medical Session #4: Advocacy Session #5: Generic drugs in CML
- CML generics: Status quo and the CML Declaration (Sarunas Narbutas) – PDF – Video Webstream
- Clinicians Perspectives on CML Generics:
- Example Latin America (Carolina Pavlovsky) – PDF – Video Webstream
- Example Serbia (Ivana Urosevic) – PDF – Video Webstream
- Example Germany (Andreas Hochhaus) – PDF – Video Webstream
- Debate: What can we do to advocate for quality generics? (Jan Geissler, Giora Sharf, Rod Padua, Sarunas Narbutas, Milena Remic) – Video Webstream
Advocacy Session #6: Joint action and Community Advisory Boards
- Community Advisory Boards: A powerful tool for the impatient patient (David Haerry) – PDF – Video Webstream
- The CML Community Advisory Board: Status Quo, Learnings and Next Steps (Jan Geissler & Giora Sharf) – PDF – Video Webstream
- “World CML Day: Achievements and outlook” (Celia Marín) – PDF – Video Webstream
- Debate: How do we improve our impact as a CML community? Video Webstream
Best Poster, Clossing and Farewell – Video Webstream